FDA Sounds Alert on Anemia Drugs
- 2 May 2007
- journal article
- other
- Published by American Medical Association (AMA) in JAMA
- Vol. 297 (17) , 1865-1869
- https://doi.org/10.1001/jama.297.17.1868
Abstract
Off-label use of erythropoiesis-stimulating agents (ESAs), a class of genetically engineered drugs for treatment of anemia, increases mortality and morbidity riKeywords
This publication has 0 references indexed in Scilit: